Free Trial
OTCMKTS:MAYNF

Mayne Pharma Group (MAYNF) Stock Price, News & Analysis

Mayne Pharma Group logo
$3.95 0.00 (0.00%)
As of 05/1/2025

About Mayne Pharma Group Stock (OTCMKTS:MAYNF)

Key Stats

Today's Range
$3.95
$3.95
50-Day Range
$3.95
$4.60
52-Week Range
$2.42
$4.60
Volume
N/A
Average Volume
1,887 shs
Market Capitalization
N/A
P/E Ratio
109.72
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Mayne Pharma Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
0th Percentile Overall Score

MAYNF MarketRank™: 

Mayne Pharma Group scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Mayne Pharma Group.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mayne Pharma Group is 109.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.94.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mayne Pharma Group is 109.72, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.74.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Mayne Pharma Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Mayne Pharma Group does not currently pay a dividend.

  • Dividend Growth

    Mayne Pharma Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Mayne Pharma Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Mayne Pharma Group this week, compared to 0 articles on an average week.
Receive MAYNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter.

MAYNF Stock News Headlines

MAYNF Mayne Pharma Group Limited
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

MAYNF Stock Analysis - Frequently Asked Questions

Mayne Pharma Group's stock was trading at $2.79 at the beginning of 2025. Since then, MAYNF shares have increased by 41.6% and is now trading at $3.95.
View the best growth stocks for 2025 here
.

Mayne Pharma Group's stock reverse split on Wednesday, January 18th 2023. The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of MAYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
OTCMKTS:MAYNF
CIK
N/A
Fax
N/A
Employees
780
Year Founded
N/A

Profitability

Trailing P/E Ratio
109.72
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:MAYNF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners